Administrator of Group External Communications
With a holistic approach, we design and develop medicines and intelligent devices that provide ongoing care for patients beyond their treatment. This includes new medications to treat conditions such as cancer or multiple sclerosis (MS), but also innovative technologies that make life easier for patients. For example, our injection device and disease monitoring software allow patients with MS to self-inject their medicine and monitor its administration. With cancer, our precise approach uses biomarkers that can match potential treatment to individual patients.